UCB wins wider Fintepla label, setting up showdown with Jazz’s Epidiolex
March 28, 2022‘In the long-term interests:’ FDA oncology chief defends rejection of Lilly, Innovent cancer drug
March 28, 2022FDA halts use of GlaxoSmithKline and Vir’s COVID-19 drug Xevudy in 8 northeast states
kdunleavy
Mon, 03/28/2022 – 09:19
